Avenue Therapeutics
preclinical in studies demonstrate efficacy in multiple anxiety models | Avenue Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
October 2022
Slide
16 of 30
Related slides by other companies
Enochian Biosciences
Investor Presentation
January 2024
study strategy companies often the full study to a cro there are large costs associated with layers of project management in this model and risks to meeting regulatory requirements by ceding full control initial estimates based upon prior experience with the full service cro model aggregated to approximately million for the phase i study by adopting a model where assumes more of the project management and parses out responsibility to vendors focusing on their strengths without their overhead costs budget reduced by an estimated while maintaining full control and full service | Enochian Biosciences
Ocuphire Pharma
Results
October 2022
preclinical enabling studies | Ocuphire Pharma
Freeman Capital Management
Activist
May 2023
preclinical safety studies | Freeman Capital Management
Alkermes
Investor Day
March 2021
tumor targeted split advancing toward preclinical proof of concept and cell line development engineer tumor targeted subunits fused to proprietary tumor targeting antibody demonstrate that tumor targeted subunits are retained in tumors with expected kinetics demonstrate that sequentially administered subunits combine to form functional and drive dose dependent production in humanized mice complete humanization of tumor targeting antibodies ongoing characterize lead candidates and preclinical proof of concept studies planned initiate cell line development | Alkermes
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io